• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多粘菌素B可减少大鼠全胃肠外营养期间的盲肠菌群、肿瘤坏死因子生成及肝脂肪变性。

Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat.

作者信息

Pappo I, Becovier H, Berry E M, Freund H R

机构信息

Department of Surgery, Hebrew University-Hadassah Medical School Jerusalem, Israel.

出版信息

J Surg Res. 1991 Aug;51(2):106-12. doi: 10.1016/0022-4804(91)90078-z.

DOI:10.1016/0022-4804(91)90078-z
PMID:1907698
Abstract

Hepatic complications are common in patients receiving total parental nutrition (TPN) and who have no underlying liver disease. In the present study we examined the hypothesis that endotoxin (LPS) or possibly TNF derived from the overgrowth of intestinal gram-negative bacteria is responsible for TPN-associated hepatic steatosis, and that bowel decontamination and specific anti-LPS activity of polymyxin B will reduce fatty infiltration of the liver during TPN. Forty-five male Sabra rats underwent jugular vein cannulation, were placed in metabolic cages, and were randomized into five groups. Group I was continuously infused with normal saline and allowed food ad lib, while group II-V were continuously infused with a TPN formula containing 4.25% amino acids and 25% dextrose for a total of 36 calories and 3.0 g protein per 100 g body weight/day. In addition, groups III-IV were also treated by oral polymyxin B while Groups IV and V received a combination of neomycin, metronidazole, and vancomycin (NMV). Thus, Group III received polymyxin B, Group IV received both polymyxin B and NMV, while Group V received NMV only. On Days 7-8 of the study, all animals were sacrificed and spontaneous production of TNF by peritoneal macrophages, bacterial translocation to mesenteric lymph nodes, culture of the cecum, and fat, triglyceride, and cholesterol contents of the liver were determined. All groups infused with TPN exhibited higher levels of total fat, triglycerides, and cholesterol compared to the free feeding control group (P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

肝并发症在接受全胃肠外营养(TPN)且无潜在肝脏疾病的患者中很常见。在本研究中,我们检验了以下假设:源于肠道革兰氏阴性菌过度生长的内毒素(LPS)或可能的TNF是TPN相关肝脂肪变性的原因,并且肠道去污和多粘菌素B的特异性抗LPS活性将减少TPN期间肝脏的脂肪浸润。45只雄性Sabra大鼠进行颈静脉插管,置于代谢笼中,并随机分为五组。第一组持续输注生理盐水并随意进食,而第二至五组持续输注含4.25%氨基酸和25%葡萄糖的TPN配方,每100克体重/天总共提供36千卡热量和3.0克蛋白质。此外,第三至四组还接受口服多粘菌素B治疗,第四和五组接受新霉素、甲硝唑和万古霉素(NMV)联合治疗。因此,第三组接受多粘菌素B,第四组接受多粘菌素B和NMV,而第五组仅接受NMV。在研究的第7 - 8天,处死所有动物,测定腹膜巨噬细胞自发产生TNF的情况、细菌向肠系膜淋巴结的移位、盲肠培养情况以及肝脏的脂肪、甘油三酯和胆固醇含量。与自由进食对照组相比,所有输注TPN的组总脂肪、甘油三酯和胆固醇水平均较高(P < 0.001)。(摘要截断于250字)

相似文献

1
Polymyxin B reduces cecal flora, TNF production and hepatic steatosis during total parenteral nutrition in the rat.多粘菌素B可减少大鼠全胃肠外营养期间的盲肠菌群、肿瘤坏死因子生成及肝脂肪变性。
J Surg Res. 1991 Aug;51(2):106-12. doi: 10.1016/0022-4804(91)90078-z.
2
Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat.抗肿瘤坏死因子抗体可减轻大鼠全胃肠外营养及肠道休息期间的肝脂肪变性。
JPEN J Parenter Enteral Nutr. 1995 Jan-Feb;19(1):80-2. doi: 10.1177/014860719501900180.
3
Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide.多黏菌素B通过其抗菌活性以及阻断脂多糖的有害作用,减少全胃肠外营养相关的肝脂肪变性。
JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6):529-32. doi: 10.1177/0148607192016006529.
4
Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels.全胃肠外营养中的肝脂肪变性:脂肪浸润与血清肝酶水平异常不相关
Surgery. 1986 Oct;100(4):697-704.
5
Pentoxifylline and thalidomide fail to reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat.己酮可可碱和沙利度胺在大鼠全胃肠外营养和肠道休息期间未能减轻肝脂肪变性。
JPEN J Parenter Enteral Nutr. 1997 Jul-Aug;21(4):233-4. doi: 10.1177/0148607197021004233.
6
Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats.在大鼠全胃肠外营养中添加L-谷氨酰胺及其对门静脉胰岛素和胰高血糖素以及肝脂肪变性发展的影响。
J Surg Res. 1990 May;48(5):421-6. doi: 10.1016/0022-4804(90)90006-n.
7
The enhanced effect of parenteral nutrition on hepatotoxicity.
Nutrition. 1996 Jan;12(1):30-5. doi: 10.1016/0899-9007(95)00014-3.
8
Polymyxin B prevents increased sympathetic activity and alveolar macrophage tumor necrosis factor release in parenterally fed rats.多粘菌素B可预防胃肠外营养大鼠交感神经活动增强及肺泡巨噬细胞肿瘤坏死因子释放。
Arch Surg. 1995 Dec;130(12):1294-9; discussion 1299-300. doi: 10.1001/archsurg.1995.01430120048007.
9
Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats.在全胃肠外营养(TPN)中添加胰高血糖素可预防大鼠肝脂肪变性。
Surgery. 1988 Aug;104(2):350-7.
10
Pathogenesis of hepatic steatosis in the parenterally fed rat.经肠外营养喂养大鼠肝脂肪变性的发病机制
J Clin Invest. 1984 Nov;74(5):1658-68. doi: 10.1172/JCI111582.

引用本文的文献

1
The intestinal microbiome associated with lipid metabolism and obesity in humans and animals.人与动物的脂代谢和肥胖相关的肠道微生物组。
J Appl Microbiol. 2022 Nov;133(5):2915-2930. doi: 10.1111/jam.15740. Epub 2022 Aug 8.
2
Intestinal Barrier and Permeability in Health, Obesity and NAFLD.健康、肥胖和非酒精性脂肪性肝病中的肠道屏障与通透性
Biomedicines. 2021 Dec 31;10(1):83. doi: 10.3390/biomedicines10010083.
3
Intestinal Barrier in Human Health and Disease.肠道屏障在人类健康和疾病中的作用
Int J Environ Res Public Health. 2021 Dec 6;18(23):12836. doi: 10.3390/ijerph182312836.
4
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease.非酒精性脂肪性肝病进展过程中的肠道微生物群及其代谢产物
Hepatoma Res. 2021 Jan 13;7:11. doi: 10.20517/2394-5079.2020.134. eCollection 2021.
5
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk.肝脂肪变性、肠-肝轴、微生物群与环境因素。一场永无休止的双向交互作用。
J Clin Med. 2020 Aug 14;9(8):2648. doi: 10.3390/jcm9082648.
6
You Are What You Eat-The Relationship between Diet, Microbiota, and Metabolic Disorders-A Review.你吃什么就是什么——饮食、微生物组和代谢紊乱之间的关系——综述。
Nutrients. 2020 Apr 15;12(4):1096. doi: 10.3390/nu12041096.
7
Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease.肠道微生物群中产内毒素菌过度生长引发非酒精性脂肪性肝病。
mBio. 2020 Feb 4;11(1):e03263-19. doi: 10.1128/mBio.03263-19.
8
Lipopolysaccharide promoted proliferation and adipogenesis of preadipocytes through JAK/STAT and AMPK-regulated cPLA2 expression.脂多糖通过 JAK/STAT 和 AMPK 调节的 cPLA2 表达促进前体脂肪细胞的增殖和脂肪生成。
Int J Med Sci. 2019 Jan 1;16(1):167-179. doi: 10.7150/ijms.24068. eCollection 2019.
9
Interactions of Gut Microbiota, Endotoxemia, Immune Function, and Diet in Exertional Heatstroke.运动性中暑中肠道微生物群、内毒素血症、免疫功能和饮食之间的相互作用
J Sports Med (Hindawi Publ Corp). 2018 Apr 16;2018:5724575. doi: 10.1155/2018/5724575. eCollection 2018.
10
Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.法尼酯X受体基因敲除小鼠中西方饮食诱导的肠道菌群失调在抗生素治疗后导致持续性肝脏炎症。
Am J Pathol. 2017 Aug;187(8):1800-1813. doi: 10.1016/j.ajpath.2017.04.019. Epub 2017 Jul 12.